Ad
related to: editas medicine patents
Search results
Editas Medicine, Inc. (NASDAQ:EDIT) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 months agoEditas Medicine, Inc. (NASDAQ:EDIT) Q3 2023 Earnings Call Transcript November 3, 2023 Editas...
Editas Just Caught a Break Thanks to Vertex Pharmaceuticals
Motley Fool via Yahoo Finance· 5 months agoIt's fair to say that Editas Medicine (NASDAQ: EDIT) is an ailing biotech. Over the past three...
Editas cashes in on CRISPR patent with Vertex deal
BioPharma Dive via Yahoo Finance· 6 months agoDive Brief: Days after winning U.S. approval of the first CRISPR gene-editing medicine, Vertex Pharmaceuticals is clearing up potential intellectual...
Editas (EDIT) Q1 Earnings & Revenues Lag Estimates, Stock Down
Zacks via Yahoo Finance· 4 weeks agoEditas Medicine, Inc. EDIT incurred a loss of 76 cents per share in the first quarter of 2024, wider...
Editas (EDIT) Licenses Cas9 Tool to Vertex, Stock Up 6%
Zacks via Yahoo Finance· 6 months agoEditas (EDIT) stock rises 6% on a non-exclusive agreement with Vertex Pharmaceuticals to license its...
Why Is Editas (EDIT) Down 26.2% Since Last Earnings Report?
Zacks via Yahoo Finance· 2 months agoA month has gone by since the last earnings report for Editas Medicine (EDIT). Shares have lost...
Q1 2024 Editas Medicine Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 4 weeks agoParticipants Christy Barnhart; IR; Editas Medicine, Inc. Gilmore O’Neill; CEO, President; Editas Medicine, Inc. Baisong Mei; EVP, Chief Medical Officer; Editas Medicine, Inc. Linda Burkly; EVP ...
Biotech Stock Roundup: BLUE, CRSP & VRTX Get Gene Therapy Nod, ACAD Up on Patent News
Zacks via Yahoo Finance· 6 months agoIt was a busy week for the biotech sector, with important treatment approvals and other pipeline...
Analyst Initiates Coverage On This Peer Lagging Gene-Editing Stock
Benzinga via Yahoo Finance· 1 year agoCantor Fitzgerald initiated coverage on Editas Medicine Inc (NASDAQ: EDIT) with an Overweight rating...
Bull of the Day: CRISPR Therapeutics (CRSP)
Zacks via Yahoo Finance· 6 months agoCRISPR Therapeutics (CRSP) just made history on Friday with the first FDA-approved gene-editing medicine based on the Nobel Prize-winning discovery that...
